Check out this video that captures some of the highlights of Morgo 2009. The 2010 conference, with a theme of Taking Calculated Risks, is shaping up to be another great two days.

Proacta’s lead compound, PR104, has entered Phase 2 clinical trials. This is an exciting milestone for the company. After showing signs of activity in early Phase 1 clinical trials – which establish how much of the drug can safely be administered, PR104 is now being evaluated in Phase 2 trials to test its efficacy for both liver cancer and lung cancer. These trials are being conducted in New Zealand, Asia, Canada, and the US. Results should be available by mid-2010.

No 8 Ventures co-led the Series A investment in Proacta five years ago, basing its investment decision on the increasing evidence that hypoxia (shortage of oxygen) is important in solid tumours and the world-leading intellectual property in this area developed by scientists at the University of Auckland and Stanford University, which formed the basis for the company.
For more, see www.proacta.com

Here’s Jenny’s quick take on venture capital in NZ from Radio NZ nine to noon.

We’re pleased to announce that Anthony Romano has joined the board of the Martin Aircraft Company.  Anthony is the former head of Luna Rossa’s 2007 America’s Cup syndicate, and prior to this was CEO of Calvin Klein Europe. His capability in building world class brands and his track record in developing businesses in the European market makes him an excellent fit within an already strong board.  In particular Anthony brings a real insight into the minds of the target customers for the Martin Jetpack – high net worth individuals with a sense of adventure.

Compelled to comment on the post below from Alarm Clock which was taking a look at investment levels across start-ups developing robotics technologies.
“Venture capitalists tend to be fairly conservative people – despite their reputation for risk taking. Consequently, few robot-makers have received venture funding as many VCs put the likelihood of robot products succeeding on a par with anyone conquering jet-pack transportation”.
Well, not so at No 8 Ventures.  The Martin Jetpack hit world headlines in July this year.  What’s more, we are excited about the prospect of introducing a very cool robotics company soon.

Surveylab and the ikeGPS product is having a real impact on the GPS handheld market. This review by Don Jewell, the editor of GPS World, is worth a read. We particularly liked his summary: ‘for their specific purpose they are certainly the best GPS devices I have ever seen or used, and the degree with which they can be upgraded and customized seems to be endless. The ike GPS is a range of devices our warfighters need to have .. now, and devices that our firefighters and police departments and other organizations could benefit from as well. I look forward to hearing…about all the uses and in what circumstances they have employed the capabilities of this incredible GPS-based device.’

Martin Aircraft Company today unveiled the world’s first practical jetpack at Airventure, Oshkosh, Wisconsin.  This is the culmination of nearly 30 years of research and development by Glenn Martin and a team of avionic, technical, design and production experts.  For the next week the Martin Jetpack features as one of the star attractions alongside Virgin Galactic and the Boeing Dreamliner at the world’s largest air show.   Martin Aircraft Company, then in a garage, received initial investment from the No 8 Ventures in 2003 and we have worked intensively with the company for the past 5 years to reach this point.  In 2005, the 9th prototype achieved sustained flight times, laying the foundation for a viable and successful pre-production prototype to be developed.  In 2008, the world’s first practical jetpack was launched.